23 März 2020

From tree to money faster and more efficiently than ever

Futurity to license MetGen’s award-winning METNIN™ technology for lignin valorization

Futurity, whose mission is to outperform oil with trees through the production of advanced chemicals and materials from plantation forestry in New Zealand has finalized a licensing agreement with the Finnish company MetGen Oy. Cooperation will allow the development of a full range of high value lignin-based products including resins and adhesives, foams, composites, bio-based chemicals and polymers to meet the growing needs of a fast changing world.

MetGen is a pioneer in lignocellulosic industrial enzymes and renewable chemicals. The license is for MetGen’s METNIN™ technology platform which facilitates the enzymatic break down of Futurity’s lignin into its fundamental component parts. “Lignin has vast potential to outperform and reduce our dependency on oil, historically the value and usefulness of lignin has been difficult to unlock through a commercially viable process at scale. MetGen’s METNIN™ technology has overcome this barrier and will allow us to create high quality, low cost products that unlock the true value of the lignin.  This helps us to generate value from the entire tree including cellulose, hemicellulose and lignin which makes up around 25% of total mass” said Dr. Gaetano Dedual.

MetGen’s CEO Alex Michine said “Over the past years MetGen has accumulated extensive experience on applying enzymes in industrial bio refineries”. In this work, we have recognized how important it is to match the proper technologies throughout the value-chain. This is why we are excited about being the partner in Futurity project with our METNIN™ platform.  Every processing step and every fraction of the raw material counts when creating renewable –and affordable – chemicals and materials out of lignocellulosic biomass.”

For more information, please contact:

Alex Michine,
Skype: alexmichine

Source: MetGen Oy, press release, 2020-03-09.


Share on Twitter+1Share on FacebookShare on XingShare on LinkedInShare via email